2015 Publications

'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy

Cardillo, G., Mokhles, S., Williams, N., Macbeth, F., Russell, C., Treasure, T. (2015). Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy. BRITISH JOURNAL OF CANCER, 113 (11), 1636. doi:10.1038/bjc.2015.331

issuu Widget Placeholder33644033/62959599

In Regard to Hepel and Wazer

Vaidya, J. S., Bulsara, M., Wenz, F., Joseph, D., Saunders, C., Massarut, S., Flyger, H., Eiermann, W., Alvarado, M., Esserman, L., Falzon, M., Brew-Graves, C., Potyka, I., Tobias, J., Baum, M. (2015). In Regard to Hepel and Wazer. International Journal of Radiation Oncology Biology Physics, 92(5), 953-954. doi:10.1016/j.ijrobp.2015.05.038

issuu Widget Placeholder33644033/62959674

Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer

Vaidya, J. S., Bulsara, M., Wenz, F., Joseph, D., Saunders, C., Massarut, S., Flyger, H., Eiermann, W., Alvarado, M., Esserman, L., Falzon, M., Brew-Graves, C., Potyka, I., Tobias, J., Baum, M. (2015). Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 491-497. doi:10.1016/j.ijrobp.2015.03.022

issuu Widget Placeholder33644033/62959771

Research Departments

Materials and Tissue

Tissue and Energy